SE0300830D0 - New formulations and use thereof - Google Patents

New formulations and use thereof

Info

Publication number
SE0300830D0
SE0300830D0 SE0300830A SE0300830A SE0300830D0 SE 0300830 D0 SE0300830 D0 SE 0300830D0 SE 0300830 A SE0300830 A SE 0300830A SE 0300830 A SE0300830 A SE 0300830A SE 0300830 D0 SE0300830 D0 SE 0300830D0
Authority
SE
Sweden
Prior art keywords
new formulations
formulation
tolterodine
manufacturing
cocoa powder
Prior art date
Application number
SE0300830A
Other languages
English (en)
Swedish (sv)
Inventor
Fredrik Nicklasson
Kristina Thyresson
Nils-Olof Lindberg
Alice C Martino
Kristina Lindell
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0300830A priority Critical patent/SE0300830D0/xx
Publication of SE0300830D0 publication Critical patent/SE0300830D0/xx
Priority to MXPA05010314A priority patent/MXPA05010314A/es
Priority to AU2004224556A priority patent/AU2004224556A1/en
Priority to EP04720944A priority patent/EP1605920A1/fr
Priority to BRPI0408743-7A priority patent/BRPI0408743A/pt
Priority to CNA2004800080871A priority patent/CN1764441A/zh
Priority to PCT/IB2004/000859 priority patent/WO2004084864A1/fr
Priority to JP2006506376A priority patent/JP2006521347A/ja
Priority to CA002519119A priority patent/CA2519119A1/fr
Priority to ARP040100982A priority patent/AR043773A1/es
Priority to CL200400625A priority patent/CL2004000625A1/es
Priority to US10/816,673 priority patent/US20040191345A1/en
Priority to ZA200506710A priority patent/ZA200506710B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/22Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2068Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
SE0300830A 2003-03-26 2003-03-26 New formulations and use thereof SE0300830D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE0300830A SE0300830D0 (sv) 2003-03-26 2003-03-26 New formulations and use thereof
CA002519119A CA2519119A1 (fr) 2003-03-26 2004-03-16 Formulations contenant de la tolterodine et de la poudre de cacao et leur utilisation
BRPI0408743-7A BRPI0408743A (pt) 2003-03-26 2004-03-16 formulações compreendendo tolterodina e cacau em pó e sua utilização
AU2004224556A AU2004224556A1 (en) 2003-03-26 2004-03-16 Formulations comprising tolterodine and cocoa powder and use thereof
EP04720944A EP1605920A1 (fr) 2003-03-26 2004-03-16 Formulations contenant de la tolterodine et de la poudre de cacao et leur utilisation
MXPA05010314A MXPA05010314A (es) 2003-03-26 2004-03-16 Nuevas formulaciones y su uso.
CNA2004800080871A CN1764441A (zh) 2003-03-26 2004-03-16 包含托特罗定和可可粉的制剂及其用途
PCT/IB2004/000859 WO2004084864A1 (fr) 2003-03-26 2004-03-16 Formulations contenant de la tolterodine et de la poudre de cacao et leur utilisation
JP2006506376A JP2006521347A (ja) 2003-03-26 2004-03-16 トルテロジン及びココアパウダーを含有する製剤及びその使用
ARP040100982A AR043773A1 (es) 2003-03-26 2004-03-24 Formulaciones y su uso
CL200400625A CL2004000625A1 (es) 2003-03-26 2004-03-24 Composicion farmaceutica que comprende tolterodina y cacao en polvo; su uso en la fabricacion de medicamento util para el tratamiento de vejiga hiperactiva.
US10/816,673 US20040191345A1 (en) 2003-03-26 2004-04-02 New formulations and use thereof
ZA200506710A ZA200506710B (en) 2003-03-26 2005-08-22 Formulations comprising tolterodine and cocoa powder and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300830A SE0300830D0 (sv) 2003-03-26 2003-03-26 New formulations and use thereof

Publications (1)

Publication Number Publication Date
SE0300830D0 true SE0300830D0 (sv) 2003-03-26

Family

ID=20290785

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300830A SE0300830D0 (sv) 2003-03-26 2003-03-26 New formulations and use thereof

Country Status (12)

Country Link
EP (1) EP1605920A1 (fr)
JP (1) JP2006521347A (fr)
CN (1) CN1764441A (fr)
AR (1) AR043773A1 (fr)
AU (1) AU2004224556A1 (fr)
BR (1) BRPI0408743A (fr)
CA (1) CA2519119A1 (fr)
CL (1) CL2004000625A1 (fr)
MX (1) MXPA05010314A (fr)
SE (1) SE0300830D0 (fr)
WO (1) WO2004084864A1 (fr)
ZA (1) ZA200506710B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1907136B (zh) * 2006-07-28 2010-08-25 张新生 植物保健乳及其加工方法
EP3366287B1 (fr) 2007-06-13 2020-12-23 Otsuka Pharmaceutical Co., Ltd. Boisson et gelée contenant de l'équol
JP5702926B2 (ja) 2009-10-16 2015-04-15 東レ・ダウコーニング株式会社 拭取り紙用処理剤組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB918955A (en) * 1960-05-19 1963-02-20 Thomae Gmbh Dr K Pharmaceutical laxative compositions comprising 4,4-dihydroxy-2-amino triphenylmethane
SE9803986D0 (sv) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
JP2001114668A (ja) * 1999-10-13 2001-04-24 Meiji Seika Kaisha Ltd チョコレート剤
EE05191B1 (et) * 1999-11-11 2009-08-17 Pharmacia Ab Farmatseutiline kompositsioon, mis sisaldab tolterodiini, ja selle kasutamine

Also Published As

Publication number Publication date
AU2004224556A1 (en) 2004-10-07
AR043773A1 (es) 2005-08-10
JP2006521347A (ja) 2006-09-21
WO2004084864A1 (fr) 2004-10-07
CN1764441A (zh) 2006-04-26
EP1605920A1 (fr) 2005-12-21
BRPI0408743A (pt) 2006-03-28
CL2004000625A1 (es) 2005-01-07
MXPA05010314A (es) 2006-05-19
ZA200506710B (en) 2006-11-29
CA2519119A1 (fr) 2004-10-07

Similar Documents

Publication Publication Date Title
WO2003075857A3 (fr) Composes a base de tetracycline a substitution aminomethyle
DK1525177T3 (da) Substituerede 1,3-diphenylprop-2-en-1-on-derivater, fremstilling og anvendelse deraf
PT1478339E (pt) Formulações farmacêuticas de agentes antineoplásticos, em particular temozolomida, processos para a sua produção e utilização
EP1399414A4 (fr) Composes de tetracycline substitues destines au traitement de la malaria
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
SE0100901D0 (sv) New composition
SE0302811D0 (sv) Novel compounds
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
SE0202539D0 (sv) Compounds
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
SE0300831D0 (sv) New formulations and use therof
SE0103211D0 (sv) New formulations and use thereof
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
IL175303A0 (en) Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same
HRP20070291T3 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
HRP20031057B1 (hr) Tableta koja sadrži cetirizin i pseudoefedrin
WO2005030142A8 (fr) Formulations de rifalazil
ATE353231T1 (de) Pharmazeutische zusammensetzungen
SE0300830D0 (sv) New formulations and use thereof
SE0202365D0 (sv) New formulation and use thereof
SE0001916D0 (sv) Novel formulation